Miromatrix Medical Future Growth
Future criteria checks 2/6
Miromatrix Medical is forecast to grow earnings and revenue by 13.5% and 77.7% per annum respectively while EPS is expected to grow by 26.2% per annum.
Key information
13.5%
Earnings growth rate
26.2%
EPS growth rate
| Life Sciences earnings growth | 17.5% |
| Revenue growth rate | 77.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 30 Oct 2023 |
Recent future growth updates
Recent updates
Miromatrix Medical (NASDAQ:MIRO) Will Have To Spend Its Cash Wisely
Oct 28
We're A Little Worried About Miromatrix Medical's (NASDAQ:MIRO) Cash Burn Rate
Jul 01Here's Why We're A Bit Worried About Miromatrix Medical's (NASDAQ:MIRO) Cash Burn Situation
Mar 08Here's Why We're Watching Miromatrix Medical's (NASDAQ:MIRO) Cash Burn Situation
Sep 30Miromatrix gets US patent for recellularizing technology for use in organ transplant
Aug 25Miromatrix Medical GAAP EPS of -$0.40 misses by $0.07, revenue of $3.95M
Aug 15Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 0 | -55 | N/A | N/A | 2 |
| 12/31/2024 | 0 | -36 | N/A | N/A | 2 |
| 12/31/2023 | 0 | -27 | N/A | N/A | 2 |
| 9/30/2023 | 1 | -27 | -25 | -24 | N/A |
| 6/30/2023 | 1 | -29 | -27 | -27 | N/A |
| 3/31/2023 | 1 | -30 | -28 | -28 | N/A |
| 12/31/2022 | 1 | -30 | -28 | -27 | N/A |
| 9/30/2022 | 0 | -28 | -30 | -27 | N/A |
| 6/30/2022 | 0 | -26 | -27 | -23 | N/A |
| 3/31/2022 | 0 | -21 | -24 | -20 | N/A |
| 12/31/2021 | 0 | -15 | -18 | -15 | N/A |
| 9/30/2021 | 0 | -10 | -12 | -10 | N/A |
| 6/30/2021 | 0 | -8 | -9 | -9 | N/A |
| 3/31/2021 | 0 | -8 | -8 | -8 | N/A |
| 12/31/2020 | 0 | -10 | -8 | -8 | N/A |
| 12/31/2019 | 0 | -5 | -8 | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MIRO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: MIRO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: MIRO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: MIRO's revenue (77.7% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: MIRO's revenue (77.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MIRO's Return on Equity is forecast to be high in 3 years time